L-Argininic Acid-13C6
CAS: 157-07-3
Ref. 3D-AAA15707
5g | Discontinued | ||
1mg | Discontinued | ||
2mg | Discontinued | ||
5mg | Discontinued | ||
10mg | Discontinued | ||
25mg | Discontinued | ||
250mg | Discontinued | ||
500mg | Discontinued | ||
2500mg | Discontinued |
Product Information
- (2S)-5-[(Aminoiminomethyl)amino]-2-hydroxypentanoic acid
- (2S)-5-[(diaminomethylidene)amino]-2-hydroxypentanoic acid
- (S)-5-Guanidino-2-hydroxypentanoic acid
- <span class="text-smallcaps">L</span>-Argininic acid
- Argininic acid
- L-Argininic acid L-~-Hydroxy-D-guanidino-N-valeric acid
- Pentanoic acid, 5-[(aminoiminomethyl)amino]-2-hydroxy-, (2S)-
- Pentanoic acid, 5-[(aminoiminomethyl)amino]-2-hydroxy-, (S)-
- Valeric acid, 5-guanidino-2-hydroxy-, <span class="text-smallcaps">L</span>-
- Valeric acid, 5-guanidino-2-hydroxy-, L-
- See more synonyms
L-Argininic Acid-13C6 is a basic protein that has been synthesized for the purpose of investigating enzyme inhibitors. The 13C6 is a glycol ester and sodium citrate, which are used to stabilize the molecule and allow for its use in experiments. L-Argininic Acid-13C6 has shown to inhibit the activities of enzymes such as dextran sulfate, nitrogen atoms, gsh-px activities, and human serum enzymes. It also inhibits HIV infection by blocking virus entry into cells. L-Argininic Acid-13C6 can be used as a magnesium salt to study hydrogen bonding interactions with locomotor activity.